(Received for publication, March 28, 1996, and in revised form, June 26, 1996)

From Regeneron Pharmaceuticals, Inc., Tarrytown, New York 10591-6707

Despite the widespread use of polypeptide growth factors as pharmacological agents, little is known about the extent to which these molecules regulate their cognate cell surface receptors and signal transduction pathways in vivo. We have addressed this issue with respect to the neurotrophic molecule ciliary neurotrophic factor (CNTF). Administration of CNTF in vivo resulted in modest decreases in levels of CNTFR mRNA and protein in skeletal muscle. CNTF causes the rapid tyrosine phosphorylation of LIFR and gp130 and the induction of the immediate-early gene, tis11; injection of CNTF 3-7 h after an initial exposure failed to re-stimulate these immediate-early responses, suggesting a biochemical desensitization to CNTF not accounted for by decreased receptor protein. To determine whether the desensitization of immediate-early responses caused by CNTF resulted in a functional desensitization, we compared the efficacy of multiple daily injections versus a single daily dose of CNTF in preventing the denervation-induced atrophy of skeletal muscle. Surprisingly, injections of CNTF every 6 h, which falls within the putative refractory period for biochemical responses, resulted in efficacy equal to or greater than injections once daily. These results suggest that although much of the CNTF signal transduction machinery is down-regulated with frequent CNTF dosing, biological signals continue to be recognized and interpreted by the cell.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. A. Ozog, S. M. Bernier, D. C. Bates, B. Chatterjee, C. W. Lo, and C. C.G. Naus The Complex of Ciliary Neurotrophic Factor-Ciliary Neurotrophic Factor Receptor {alpha} Up-Regulates Connexin43 and Intercellular Coupling in Astrocytes via the Janus Tyrosine Kinase/Signal Transducer and Activator of Transcription Pathway Mol. Biol. Cell, November 1, 2004; 15(11): 4761 - 4774. [Abstract] [Full Text] [PDF]

				S. Schulz-Key, H.-D. Hofmann, C. Beisenherz-Huss, C. Barbisch, and M. Kirsch Ciliary Neurotrophic Factor as a Transient Negative Regulator of Rod Development in Rat Retina Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 3099 - 3108. [Abstract] [Full Text] [PDF]

				B. Fraysse, C. Guillet, C. Huchet-Cadiou, D. C. Camerino, H. Gascan, and C. Leoty Ciliary neurotrophic factor prevents unweighting-induced functional changes in rat soleus muscle J Appl Physiol, May 1, 2000; 88(5): 1623 - 1630. [Abstract] [Full Text] [PDF]

				C. Guillet, P. Auguste, W. Mayo, P. Kreher, and H. Gascan Ciliary Neurotrophic Factor is a Regulator of Muscular Strength in Aging J. Neurosci., February 15, 1999; 19(4): 1257 - 1262. [Abstract] [Full Text] [PDF]

				A. Di Marco, I. Gloaguen, A. Demartis, I. Saggio, R. Graziani, G. Paonessa, and R. Laufer Agonistic and Antagonistic Variants of Ciliary Neurotrophic Factor (CNTF) Reveal Functional Differences between Membrane-bound and Soluble CNTF alpha -Receptor J. Biol. Chem., September 12, 1997; 272(37): 23069 - 23075. [Abstract] [Full Text] [PDF]

				R. M. Gibson, W. P. Schiemann, L. B. Prichard, J. M. Reno, L. H. Ericsson, and N. M. Nathanson Phosphorylation of Human gp130 at Ser-782 Adjacent to the Di-leucine Internalization Motif. EFFECTS ON EXPRESSION AND SIGNALING J. Biol. Chem., July 14, 2000; 275(29): 22574 - 22582. [Abstract] [Full Text] [PDF]